Tiña capitis en Niños: Pandemia aún no erradicada

Contenido principal del artículo

Sebastián Gómez Restrepo
Jairo Victoria Chaparro

Resumen

Antecedentes: la Tiña de la Cabeza o Tiña Capitis es una enfermedad propia y casi exclusiva de la infancia causada por alguna de las especies de dermatofitos usualmente de los géneros Microsporum y Trichophyton. Temática: entre los factores de riesgo asociados a la primoinfección está el uso de equipos de peluquería contaminados con los microorganismos, el contacto con animales o bien, directamente de persona a persona. El dato clínico más relevante es la aparición de una o varias placas alopécicas o pseudoalopécicas con pelos cortos y rotos, eritema, descamación y ocasionalmente la presencia de pápulas y pústulas. Metodos: revisión narrativa. Se identificaron artículos de las bases de datos ScienceDirect, Scopus, PubMed, MEDLINE y Google Scholar, publicados entre 1982 y 2021 que tuvieran en el título los términos, tiña capitis, dermatomicosis en niños, antifúngicos en niños, niños, diagnóstico de Tinea capitis, epidemiología y dermatomicosis, utilizando los conectores «AND» y «OR». Esta revisión se llevó a cabo durante un período de seis meses desde agosto de 2021 hasta enero de 2022. Resultados: la evolución de la infección puede afectar la calidad de vida de los pacientes, por lo que se vuelve imprescindible la confirmación microbiológica que permita un tratamiento adecuado. Conclusión: el manejo debe ser con medicamentos vía oral por lo menos durante cuatro semanas y entre los fármacos utilizados se encuentra la griseofulvina, terbinafina e itraconazol.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Cómo citar
Gómez Restrepo, S., & Victoria Chaparro, J. (2022). Tiña capitis en Niños: Pandemia aún no erradicada. Pediatría, 55(3), 142–149. https://doi.org/10.14295/rp.v55i3.353
Sección
Artículos de Revisión
Biografía del autor/a

Jairo Victoria Chaparro, Dermatólogo Pediátrico, Epidemiólogo, Coordinador Especialización en Dermatología Universidad Libre Seccional Cali, Colombia

Médico Dermatólogo Pediátrico.

Epidemiólogo

Coordinador Posgrado en Dermatología Universidad Libre-Cali

Citas

Zuluaga A, Cáceres DH, Arango K, De Bedout C, Cano LE. Epidemiología de la tinea capitis: 19 años de experiencia en un laboratorio clínico especializado en Colombia. Infectio. 2016;20(4)225-230. DOI: https://doi.org/10.1016/j.infect.2015.11.004

Hay, R. Tinea Capitis: Current Status. Mycopathologia. 2017;182.(1-2), 87–93. DOI: https://doi.org/10.1007/s11046-016-0058-8

Messina, F., Walker, L., Romero, M. de las M., Arechavala, A. I., Negroni, R., Depardo, R et al. Tinea capitis: clinical features and therapeutic alternatives. Rev Argent Microbiol. 2021;19:S0325-7541(21)00011-0.

Kechia FA, Kouoto EA, Nkoa T, Nweze EI, Fokoua DC, Fosso S, Somo MR. Epidemiology of tinea capitis among school-age children in Meiganga, Cameroon. J Mycol Med. 2014;24(2):129-34. DOI: https://doi.org/10.1016/j.mycmed.2013.12.002

Abdel-Rahman SM, Farrand N, Schuenemann E, et al. The prevalence of infections with Trichophyton tonsurans in schoolchildren: the CAPITIS study. Pediatrics 2010;125: 966-973. DOI: https://doi.org/10.1542/peds.2009-2522

Monod M, Fratti M, Mignon B, et al. Dermatophytes transmitted by pets and cattle. Rev Med Suisse 2014;10:749-753.

Mirmirani P, Tucker LY. Epidemiologic trends in pediatric tinea capitis: a population-based study from Kaiser Permanente Northern California. J Am Acad Dermatol 2013;69: 916–921. DOI: https://doi.org/10.1016/j.jaad.2013.08.031

Zaraá I, Hawilo A, Aounallah A, Trojjet S, El Euch D, Mokni M et al. Inflammatory Tinea capitis: a 12-year study and a review of the literature. Mycoses. 2013;56(2)110-6. DOI: https://doi.org/10.1111/j.1439-0507.2012.02219.x

Mao L, Zhang L, Li H, et al. Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome. Infect Immun 2014;82:882–892. DOI: https://doi.org/10.1128/IAI.01097-13

Takwale A, Agarwal S, Holmes SC, et al. Tinea capitis in two elderly women: transmission at the hairdresser. Br J Dermatol 2001;144:898-900. DOI: https://doi.org/10.1046/j.1365-2133.2001.04154.x

Aly R. Ecology, epidemiology, and diagnosis of tinea capitis. Pediatr Inf Dis J 1999; 18:180-185. DOI: https://doi.org/10.1097/00006454-199902000-00025

Brendan K. Superficial fungal infections. Pediatr Rev. 2012;33:e22-37. DOI: https://doi.org/10.1542/pir.33.4.e22

Negroni R, Arechavala A. Micosis superficiales de la piel y sus faneras. En: Lecciones de clínica micológica. 2 da ed Editorial Ascune; 2019. p.15-33.

Möhrenschlager M, Bruckbauer H, Seidl HP, Ring J, Hofmann H. Prevalence of asymptomatic carriers and cases of tinea capitis in five- to six-year-old preschool children from Augsburg, Germany: results from the MIRIAM study. Pediatr Infect Dis J. 2005;24:749-50. DOI: https://doi.org/10.1097/01.inf.0000172909.73601.dc

Panasiti V, Devirgiliis V, Borroni RG et al. Epidemiology of dermatophytic infections in Rome, Italy: a retrospective study from 2002 to 2004. Med Mycol 2007;45:57–60. DOI: https://doi.org/10.1080/13693780601028683

Fuller LC. Changing face of tinea capitis in Europe. Curr Opin Infect Dis 2009;22: 115-8. DOI: https://doi.org/10.1097/QCO.0b013e3283293d9b

Veasey J, Miguel B, Mayor S, Zaitz C, Muramatu L and Serrano J. Epidemiological profile of tinea capitis in São Paulo City. Anais Brasileiros de Dermatologia. 2017;92(2), 283-284. DOI: https://doi.org/10.1590/abd1806-4841.20175463

Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol 2011; 28: 655-7.

Pomeranz AJ, Fairley JA. Management error leading to unnecessary hospitalization for kerion. Pediatrics 1994; 93: 968-88. DOI: https://doi.org/10.1542/peds.93.6.986

Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ 2003; 326: 539–41. DOI: https://doi.org/10.1136/bmj.326.7388.539

Zhang R, Ran Y, Dai Y et al. A case of kerion celsi caused by Microsporum gypseum in a boy following dermatoplasty for a scalp wound from a road accident. Med Mycol 2011; 49: 90–3. DOI: https://doi.org/10.3109/13693786.2010.503196

Nenoff P, Kruger C, Schulze I et al. [Tinea capitis and onychomycosis due to Trichophyton soudanense: Successful treatment with fluconazole-literature review]. Hautarzt 2018; 69:737–50. DOI: https://doi.org/10.1007/s00105-018-4155-0

Burke WA, Jones BE. A simple stain for rapid office diagnosis of fungus infection of the skin. Arch Dermatol 1984;120:1519. DOI: https://doi.org/10.1001/archderm.1984.01650470125029

Head ES, Henry JC, MacDonald EM. The cotton swab technique for the culture of dermatophyte infections: its efficacy and merit. J Am Acad Dermatol 1984;11:797. DOI: https://doi.org/10.1016/S0190-9622(84)80455-7

Hiruma J, Ogawa Y, Hiruma M. Trichophyton tonsurans infection in Japan: epidemiology, clinical features, diagnosis and infection control. J Dermatol 2015;42: 245–249. DOI: https://doi.org/10.1111/1346-8138.12678

Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia 2008;166:295–306. DOI: https://doi.org/10.1007/s11046-008-9106-3

Verrier J, Krahenbuhl L, Bontems O et al. Dermatophyte identification in skin and hair samples using a simple and reliable nested polymerase chain reaction assay. Br J Dermatol 2013;168:295–301. DOI: https://doi.org/10.1111/bjd.12015

Sugita T, Shiraki Y, Hiruma M. Real-time PCR TaqMan assay for detecting Trichophyton tonsurans, a causative agent of tinea capitis, from hairbrushes. Med Mycol 2006;44:579–81. DOI: https://doi.org/10.1080/13693780600717153

Verrier J, Monod M. Diagnosis of dermatophytosis using molecular biology. Mycopathologia 2017;182:193–202. DOI: https://doi.org/10.1007/s11046-016-0038-z

Ghannoum MA, Wraith LA, Cai B et al. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Br J Dermatol 2008;159:711–3. DOI: https://doi.org/10.1111/j.1365-2133.2008.08648.x

Arenas R, Toussaint S, Isa-Isa R. Kerion and dermatophytic granuloma. Mycological and histopathological findings in 19 children with inflammatory tinea capitis of the scalp. Int J Dermatol. 2006;45(3):215-9. DOI: https://doi.org/10.1111/j.1365-4632.2004.02449.x

Vazquez-Lopez F, Palacios-Garcia L, Argenziano G. Dermoscopic corkscrew hairs dissolve after successful therapy of Trichophyton violaceum tinea capitis: a case report. Australas J Dermatol. 2012;53:118–9. DOI: https://doi.org/10.1111/j.1440-0960.2011.00850.x

Richarz NA, Barboza L, Monsonis M et al. Trichoscopy helps to predict the time point of clinical cure of tinea capitis. Australas J Dermatol 2018;59: e298–e299. DOI: https://doi.org/10.1111/ajd.12830

Waśkiel-Burnat A, Rakowska A, Sikora M, Ciechanowicz P, Olszewska M, Rudnicka L. Trichoscopy of Tinea Capitis: A Systematic Review. Dermatol Ther (Heidelb). 2020; 10(1):43-52. DOI: https://doi.org/10.1007/s13555-019-00350-1

Seebacher C, Abeck D, Brasch J et al. Tinea capitis: ringworm of the scalp. Mycoses. 2007;50.218–26. DOI: https://doi.org/10.1111/j.1439-0507.2006.01350.x

Fuller LC, Barton RC, Mohd Mustapa MF et al. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol 2014;171:454–63. DOI: https://doi.org/10.1111/bjd.13196

Allen h, Honig P, Leyden J and McGinley K. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics, 69 (1982), pp. 81-83. DOI: https://doi.org/10.1542/peds.69.1.81

Gupta AK, Mays RR, Versteeg SG et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol 2018;32:2264-74.

Gupta AK, Adam P, Dlova N et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001;18:433-8. DOI: https://doi.org/10.1046/j.1525-1470.2001.01978.x

Chen X, Jiang X, Yang M et al. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review. J Am Acad Dermatol 2017;76:368-74.

B.E. Elewski. Cutaneous mycoses in children. Br J Dermatol, 134 (1996), pp. 7-11. DOI: https://doi.org/10.1111/j.1365-2133.1996.tb15651.x

Gupta AK, Mays RR, Versteeg SG et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol 2018; 32:2264–74.

Chen X, Jiang X, Yang M et al. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review. J Am Acad Dermatol 2017;76: 368–74. DOI: https://doi.org/10.1016/j.jaad.2016.08.061

F. Baudrez-Rosselet, M. Monod, S. Jaccoud, E. Frenk. Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species. Br J Dermatol. 1996;135(1996)1011-1012. DOI: https://doi.org/10.1046/j.1365-2133.1996.d01-1117.x

Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br J Dermatol. 2000;143(1):53-8. DOI: https://doi.org/10.1046/j.1365-2133.2000.03530.x

Gupta AK, Mays RR, Versteeg SG et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol 2018;32:2264-74. DOI: https://doi.org/10.1111/jdv.15088

Gubbins PO, Heldenbrand S. Clinically relevant drug interactions of current antifungal agents. Mycoses 2010; 53: 95-113. DOI: https://doi.org/10.1111/j.1439-0507.2009.01820.x

Solomon BA, Collins R, Sharma R, Silverberg N, Jain AR, Sedgh J, Laude TA. Fluconazole for the treatment of tinea capitis in children. J Am Acad Dermatol. 1997;37(2 Pt 1):274-5. DOI: https://doi.org/10.1016/S0190-9622(97)80141-7

Silverman R. Using oral antifungals safely. Contemp Pediatr 2001;18:9-11. DOI: https://doi.org/10.1046/j.1525-1470.2001.1988b.x

Blumer JL. Pharmacologic basis for the treatment of tinea capitis. Pediatr Infect Dis J.1999;18:191-9. DOI: https://doi.org/10.1097/00006454-199902000-00027

Hussain I, Muzaffar F, Rashid T et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol.1999;37:97-9. DOI: https://doi.org/10.1046/j.1365-280X.1999.00199.x

Ginsburg CM, Gan VN, Petruska M. Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion. Pediatr Infect Dis J. 1987;6:1084-7. DOI: https://doi.org/10.1097/00006454-198712000-00003

Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol. 2011;28:655–7. DOI: https://doi.org/10.1111/j.1525-1470.2011.01645.x

Mayser P. Treatment of dermatoses: Significance and use of glucocorticoids in fixed combination with antifungals. Hautarzt 2016; 67:732-8. DOI: https://doi.org/10.1007/s00105-016-3851-x

Schaller M, Friedrich M, Papini M et al. Topical antifungalcorticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting. Mycoses 2016;59:365-73. DOI: https://doi.org/10.1111/myc.12481

Stolmeier DA, Stratman HB, McIntee TJ, Stratman EJ. Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections. JAMA Dermatol 2018; 154: 1409–16. DOI: https://doi.org/10.1001/jamadermatol.2018.3578

Patel D, Castelo-Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2017;153: 1326-7. DOI: https://doi.org/10.1001/jamadermatol.2017.4483

Kramer ON, Albrecht J. Clinical presentation of terbinafineinduced severe liver injury and the value of laboratory monitoring: a critically appraised topic. Br J Dermatol .2017; 177:1279-84. DOI: https://doi.org/10.1111/bjd.15854

Cestari T, Manzoni A. Patología infecciosa. En: Larralde M, Abad E, Luna P, Boggio P, Ferrari B, editores. Dermatología Pediátrica. 3a ed. Ciudad Autónoma de Buenos Aires: Journal; 2021. p.174-266.

Artículos similares

<< < 1 2 3 4 5 6 

También puede {advancedSearchLink} para este artículo.